Journal article
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidin
- Abstract:
- The peptide antibiotic albicidin is a DNA topoisomerase inhibitor with low-nanomolar bactericidal activity towards fluoroquinolone-resistant Gram-negative pathogens. However, its mode of action is poorly understood. We determined a 2.6 Å resolution cryoelectron microscopy structure of a ternary complex between Escherichia coli topoisomerase DNA gyrase, a 217 bp double-stranded DNA fragment and albicidin. Albicidin employs a dual binding mechanism where one end of the molecule obstructs the crucial gyrase dimer interface, while the other intercalates between the fragments of cleaved DNA substrate. Thus, albicidin efficiently locks DNA gyrase, preventing it from religating DNA and completing its catalytic cycle. Two additional structures of this trapped state were determined using synthetic albicidin analogues that demonstrate improved solubility, and activity against a range of gyrase variants and E. coli topoisomerase IV. The extraordinary promiscuity of the DNA-intercalating region of albicidins and their excellent performance against fluoroquinolone-resistant bacteria holds great promise for the development of last-resort antibiotics
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 8.1MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41929-022-00904-1
- Publication website:
- https://refubium.fu-berlin.de/bitstream/fub188/38306/1/s41929-022-00904-1.pdf
Authors
- Publisher:
- Nature Research
- Journal:
- Nature Catalysis More from this journal
- Volume:
- 6
- Issue:
- 1
- Pages:
- 52-67
- Publication date:
- 2023-01-23
- DOI:
- EISSN:
-
2520-1158
- ISSN:
-
2520-1158
- Language:
-
English
- Keywords:
- Pubs id:
-
2428883
- Local pid:
-
pubs:2428883
- Source identifiers:
-
W4317757459
- Deposit date:
-
2026-06-03
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record